These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 11808170)

  • 1. [Severe combined immunodeficiency disease and similar combined immunodeficiency disease].
    Nakata H; Mitsuya H
    Nihon Rinsho; 2001 Nov; 59 Suppl 7():581-7. PubMed ID: 11808170
    [No Abstract]   [Full Text] [Related]  

  • 2. [Severe combined immunodeficiency].
    Kumaki S; Tsuchiya S
    Ryoikibetsu Shokogun Shirizu; 2000; (32):38-42. PubMed ID: 11212751
    [No Abstract]   [Full Text] [Related]  

  • 3. [Severe combined immunodeficiency].
    Okawa H
    Ryoikibetsu Shokogun Shirizu; 1998; (21 Pt 2):235-9. PubMed ID: 9833479
    [No Abstract]   [Full Text] [Related]  

  • 4. Severe combined immunodeficiency--molecular pathogenesis and diagnosis.
    Gaspar HB; Gilmour KC; Jones AM
    Arch Dis Child; 2001 Feb; 84(2):169-73. PubMed ID: 11159300
    [No Abstract]   [Full Text] [Related]  

  • 5. A novel JAK3 mutation in a Japanese patient with severe combined immunodeficiency.
    Uchiyama T; Kumaki S; Fujiwara M; Nishida Y; Hakozaki I; Imai K; Du W; Yoshinari M; Sasahara Y; Tsuchiya S
    Pediatr Int; 2005 Oct; 47(5):575-8. PubMed ID: 16190968
    [No Abstract]   [Full Text] [Related]  

  • 6. [Omenn syndrome].
    Yachie A
    Ryoikibetsu Shokogun Shirizu; 2000; (32):23-6. PubMed ID: 11212702
    [No Abstract]   [Full Text] [Related]  

  • 7. Severe combined immunodeficiencies of the common gamma-chain/JAK3 signaling pathway.
    Schumacher RF; Notarangelo LD
    Isr Med Assoc J; 2002 Feb; 4(2):131-5. PubMed ID: 11875988
    [No Abstract]   [Full Text] [Related]  

  • 8. Severe combined immune deficiencies due to defects of the common gamma chain-JAK3 signaling pathway.
    Candotti F; O'Shea JJ; Villa A
    Springer Semin Immunopathol; 1998; 19(4):401-15. PubMed ID: 9618765
    [No Abstract]   [Full Text] [Related]  

  • 9. Molecular modeling of the Jak3 kinase domains and structural basis for severe combined immunodeficiency.
    Vihinen M; Villa A; Mella P; Schumacher RF; Savoldi G; O'Shea JJ; Candotti F; Notarangelo LD
    Clin Immunol; 2000 Aug; 96(2):108-18. PubMed ID: 10900158
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Jak3, severe combined immunodeficiency, and a new class of immunosuppressive drugs.
    Pesu M; Candotti F; Husa M; Hofmann SR; Notarangelo LD; O'Shea JJ
    Immunol Rev; 2005 Feb; 203():127-42. PubMed ID: 15661026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutations in severe combined immune deficiency (SCID) due to JAK3 deficiency.
    Notarangelo LD; Mella P; Jones A; de Saint Basile G; Savoldi G; Cranston T; Vihinen M; Schumacher RF
    Hum Mutat; 2001 Oct; 18(4):255-63. PubMed ID: 11668610
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new modality for immunosuppression: targeting the JAK/STAT pathway.
    O'Shea JJ; Pesu M; Borie DC; Changelian PS
    Nat Rev Drug Discov; 2004 Jul; 3(7):555-64. PubMed ID: 15232577
    [No Abstract]   [Full Text] [Related]  

  • 13. Jak3 and the pathogenesis of severe combined immunodeficiency.
    O'Shea JJ; Husa M; Li D; Hofmann SR; Watford W; Roberts JL; Buckley RH; Changelian P; Candotti F
    Mol Immunol; 2004 Jul; 41(6-7):727-37. PubMed ID: 15220007
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of a novel nonsense mutation in the interleukin 2 receptor gamma gene causing X-linked severe combined immunodeficiency.
    Cohen L; Hirschfeld AF; Junker AK; Davis J; Turvey SE
    Ann Allergy Asthma Immunol; 2006 Apr; 96(4):632. PubMed ID: 16680939
    [No Abstract]   [Full Text] [Related]  

  • 15. Severe combined immunodeficiency--an update.
    Cirillo E; Giardino G; Gallo V; D'Assante R; Grasso F; Romano R; Di Lillo C; Galasso G; Pignata C
    Ann N Y Acad Sci; 2015 Nov; 1356():90-106. PubMed ID: 26235889
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Eleven novel JAK3 mutations in patients with severe combined immunodeficiency-including the first patients with mutations in the kinase domain.
    Mella P; Schumacher RF; Cranston T; de Saint Basile G; Savoldi G; Notarangelo LD
    Hum Mutat; 2001 Oct; 18(4):355-6. PubMed ID: 11668621
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term survival in severe combined immune deficiency: the role of persistent maternal engraftment.
    Tezcan I; Ersoy F; Sanal O; Turul T; Uckan D; Balci S; Hicsonmez G; Prieur M; Caillat-Zucmann S; Le Deist F; De Saint Basile G
    J Pediatr; 2005 Jan; 146(1):137-40. PubMed ID: 15644840
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Gene therapy of primary immunodeficiencies. Present and future].
    Serrano F; Laín de Lera T; González MA; García MJ; Abad JL; Bernad A
    Sangre (Barc); 1999 Apr; 44(2):143-53. PubMed ID: 10382324
    [No Abstract]   [Full Text] [Related]  

  • 19. A retrospective single-center study of clinical presentation and outcome in 117 patients with severe combined immunodeficiency.
    Stephan JL; Vlekova V; Le Deist F; De Saint Basile G; Donadieu J; Durandy A; Blanche S; Griscelli C; Fischer A
    Immunodeficiency; 1993; 4(1-4):87-8. PubMed ID: 8167742
    [No Abstract]   [Full Text] [Related]  

  • 20. Partial immune reconstitution after bone marrow transplantation in a boy with recombination activating gene 1 defect.
    Muñoz-Robles J; Del Rey MJ; Ruiz-Contreras J; Clemente J; Ramos JT; Paz-Artal E; Allende LM
    Bone Marrow Transplant; 2004 Apr; 33(8):877-8. PubMed ID: 14990985
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.